Pilot Trial Comparing Two Different Wavelengths of Light (Blue Versus Red) During Levulan(TM)-Based Photodynamic Therapy of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2017
Price : $35 *
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Basal cell nevus syndrome
- Focus Therapeutic Use
- 01 May 2017 Status changed from active, no longer recruiting to completed.
- 01 Aug 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 18 Aug 2015 Planned initiation date changed from 1 Apr 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.